These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 26431600)

  • 21. The role of nonsteroidal anti-inflammatory drugs in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    Sheikh I; Fontenot E; Waghray N; Ismail MK; Tombazzi C; Smith JL
    JOP; 2014 May; 15(3):219-24. PubMed ID: 24865531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of pancreatic stents in prevention of post-ERCP pancreatitis.
    Freeman ML
    JOP; 2004 Sep; 5(5):322-7. PubMed ID: 15365198
    [No Abstract]   [Full Text] [Related]  

  • 23. Post-ERCP pancreatitis.
    Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
    Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reply to Kadayifci and Yildirim.
    Mariani A; Pantaleo G
    Endoscopy; 2016 Oct; 48(10):956. PubMed ID: 27669473
    [No Abstract]   [Full Text] [Related]  

  • 26. Incidence, risk factors, and prevention of post-ERCP pancreatitis.
    Cooper ST; Slivka A
    Gastroenterol Clin North Am; 2007 Jun; 36(2):259-76, vii-viii. PubMed ID: 17533078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postendoscopic Retrograde Cholangiopancreatography Pancreatitis Pathophysiology and Prevention.
    Akshintala VS; Singh VK
    Gastrointest Endosc Clin N Am; 2023 Oct; 33(4):771-787. PubMed ID: 37709410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-ERCP pancreatitis and its prevention.
    Frank CD; Adler DG
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):680-8. PubMed ID: 17130878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?
    Cheon YK
    Korean J Intern Med; 2013 Mar; 28(2):141-8. PubMed ID: 23525264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
    Ahmad D; Lopez KT; Esmadi MA; Oroszi G; Matteson-Kome ML; Choudhary A; Bechtold ML
    Pancreas; 2014 Apr; 43(3):338-42. PubMed ID: 24622061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of post-ERCP pancreatitis.
    Maranki J; Yeaton P
    Curr Gastroenterol Rep; 2013 Nov; 15(11):352. PubMed ID: 24193373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic stent placement remains a cornerstone of prevention of post-ERCP pancreatitis, but it requires specialized techniques.
    Arain MA; Freeman ML
    Gastrointest Endosc; 2015 Jan; 81(1):156-8. PubMed ID: 25527054
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased Use of Prophylactic Measures in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Sperna Weiland CJ; Engels MML; Poen AC; Bhalla A; Venneman NG; van Hooft JE; Bruno MJ; Verdonk RC; Fockens P; Drenth JPH; van Geenen EJM;
    Dig Dis Sci; 2021 Dec; 66(12):4457-4466. PubMed ID: 33630216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indomethacin for post-ERCP pancreatitis prophylaxis: another attempt at the Holy Grail.
    Wagh MS; Sherman S
    Am J Gastroenterol; 2007 May; 102(5):984-6. PubMed ID: 17489783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Multicenter, Prospective, Randomized Controlled Trial Evaluating the Efficacy of Rectal Diclofenac and Sublingual Nitroglycerin as a Combined Prophylactic Treatment for Post-ERCP Pancreatitis.
    Tomoda T; Kato H; Mizukawa S; Muro S; Akimoto Y; Uchida D; Matsumoto K; Yamamoto N; Horiguchi S; Tsutsumi K; Okada H
    Acta Med Okayama; 2016 Octoaber; 70(5):405-408. PubMed ID: 27777436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a cost-effectiveness analysis.
    Nicolás-Pérez D; Castilla-Rodríguez I; Gimeno-García AZ; Romero-García R; Núñez-Díaz V; Quintero E
    Pancreas; 2015 Mar; 44(2):204-10. PubMed ID: 25406954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and management of adverse events of endoscopic retrograde cholangiopancreatography.
    Balmadrid B; Kozarek R
    Gastrointest Endosc Clin N Am; 2013 Apr; 23(2):385-403. PubMed ID: 23540966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-endoscopic retrograde cholangio-pancreatography pancreatitis: is time for a new preventive approach?
    Tammaro S; Caruso R; Pallone F; Monteleone G
    World J Gastroenterol; 2012 Sep; 18(34):4635-8. PubMed ID: 23002332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases.
    Zhou W; Li Y; Zhang Q; Li X; Meng W; Zhang L; Zhang H; Zhu K; Zhu X
    Pancreatology; 2011; 11(4):399-405. PubMed ID: 21894057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of acute pancreatitis following endoscopic retrograde cholangiopancreatography].
    Patai Á; Patai ÁV; Solymosi N; Tulassay Z; Herszényi L
    Orv Hetil; 2015 May; 156(18):715-9. PubMed ID: 26042778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.